Sanara MedTech appoints Zachary B. Fleming as CEO effective January 1, 2022

Sanara MedTech Inc.

Zachary B. Fleming appointed CEO effective Jan 1, 2022; previously Co-COO & President of Surgical Division.
Base salary raised from $225,000 to $290,000; eligible for annual restricted stock award up to 75% of salary.
Eligible for annual cash bonus up to 50% of base salary; also receives customary benefits.
Fleming led surgical division through double-digit revenue growth and COVID-19 challenges.
Executive Chairman Ron Nixon expressed confidence in Fleming's leadership and strategic vision.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Zachary B. Fleming

Chief Executive Officer

SMTI · Sanara MedTech Inc.

Effective: 2021-01-01
Filed: December 28, 2021, 6:59 PM ET

On December 22, 2021, the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2021 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Zachary B. Fleming was appointed as Chief Executive Officer at Sanara MedTech Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On December 22, 2021, the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2021 (the “Effective Date”).

View on SEC.gov

Sanara MedTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-032604

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.